Current Value
$43.501 Year Return
Current Value
$43.501 Year Return
Double maintains 2 strategies that include TARS - Tarsus Pharmaceuticals, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PTH | 45.14% | $96.56M | 0.6% |
XBI | 41.06% | $4.85B | 0.35% |
GNOM | 33.92% | $40.65M | 0.5% |
IBB | 33.84% | $5.22B | 0.45% |
XPH | 33.80% | $136.58M | 0.35% |
PBE | 33.14% | $214.12M | 0.58% |
ARKG | 33.12% | $944.78M | 0.75% |
FBT | 30.78% | $994.71M | 0.56% |
IWC | 30.59% | $766.88M | 0.6% |
QQA | 29.68% | $225.66M | 0.29% |
XHE | 29.10% | $171.93M | 0.35% |
IWO | 28.98% | $11.36B | 0.24% |
BBH | 28.70% | $327.42M | 0.35% |
QMOM | 28.18% | $302.83M | 0.29% |
AIPI | 27.97% | $288.11M | 0.65% |
RYLD | 27.83% | $1.29B | 0.6% |
IWMY | 27.57% | $109.62M | 1.02% |
KJUL | 27.40% | $113.35M | 0.79% |
WCLD | 27.20% | $413.00M | 0.45% |
ISCG | 27.12% | $645.00M | 0.06% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LU | -0.01% | $2.45B | -35.82% | 0.00% |
DK | -0.03% | $1.13B | -33.14% | 6.84% |
SAFT | 0.05% | $1.23B | +2.09% | 4.33% |
AFG | 0.05% | $10.37B | -2.77% | 2.50% |
RLI | -0.06% | $6.87B | +3.80% | 1.36% |
AOS | -0.06% | $9.87B | -18.67% | 1.93% |
HAIN | 0.10% | $162.46M | -75.84% | 0.00% |
FMC | -0.11% | $4.90B | -38.86% | 5.92% |
WTW | 0.17% | $30.74B | +20.92% | 1.15% |
DV | 0.17% | $2.34B | -23.73% | 0.00% |
HLF | 0.19% | $720.06M | -36.19% | 0.00% |
VRSK | 0.20% | $42.99B | +22.22% | 0.53% |
RTX | -0.24% | $181.05B | +30.01% | 1.86% |
NOMD | 0.24% | $2.79B | -0.55% | 3.54% |
GTX | 0.26% | $2.41B | +25.45% | 0.51% |
PGNY | 0.27% | $1.88B | -20.33% | 0.00% |
LTM | -0.28% | $11.01B | -96.75% | 2.75% |
XIFR | -0.30% | $901.47M | -71.79% | 18.94% |
PGR | -0.30% | $164.82B | +35.81% | 1.74% |
AON | -0.31% | $77.43B | +22.80% | 0.77% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CGMU | 0.01% | $3.10B | 0.27% |
LTPZ | -0.01% | $673.45M | 0.2% |
JPLD | -0.05% | $1.19B | 0.24% |
SHM | 0.06% | $3.37B | 0.2% |
NEAR | 0.14% | $3.26B | 0.25% |
MUB | -0.15% | $38.67B | 0.05% |
JCPB | -0.15% | $6.25B | 0.38% |
SCHJ | -0.17% | $515.13M | 0.03% |
MMIT | -0.19% | $829.60M | 0.3% |
CXSE | 0.21% | $414.69M | 0.32% |
BSCT | 0.25% | $1.98B | 0.1% |
IAGG | -0.26% | $7.30B | 0.07% |
GRNB | -0.26% | $126.04M | 0.2% |
GTIP | -0.32% | $145.27M | 0.12% |
STPZ | -0.32% | $446.46M | 0.2% |
BSSX | 0.33% | $75.11M | 0.18% |
JPST | -0.45% | $30.82B | 0.18% |
BSCR | -0.46% | $3.49B | 0.1% |
VTEB | 0.47% | $35.64B | 0.03% |
AGGH | -0.47% | $309.35M | 0.29% |
Yahoo
The heavy selling pressure might have exhausted for Tarsus Pharmaceuticals (TARS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
SeekingAlpha
TARS boosts Xdemvy growth with aggressive TV ads, eyes expansion into ocular rosacea and Lyme disease prevention.
Yahoo
IRVINE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced that management plans to participate in the following upcoming investor conferences: Bank of America Securities 2025 Health Care Conference on Tuesday, May 13th, at 3:40 p.m. PT / 6:40 p.m. ETH.C. Wainwright & Co. 3rd Annual BioConnect Nasdaq Investor Conference on Tuesday, May 20th, at 12:00 p.m. PT / 3:00 p.m. ETStifel Virtual Ophthalmology Forum on Tuesday, May 27th, at 7:30 a.m. PT /
Finnhub
Presenter SpeechJason Gerberry The next company presenter, Tarsus Pharmaceuticals. Joining us is Jeff Farrow, Chief Strategy Officer and CFO; and Aziz Mottiwala, Chief Commercial Officer. So...
Yahoo
We recently published a list of 11 Best Breakout Stocks to Buy According to Analysts. In this article, we are going to take a look at where Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) stands against other best breakout stocks to buy according to analysts. Stock markets have been on edge in response to the US President’s aggressive […]
Yahoo
Celebrations may be in order for Tarsus Pharmaceuticals, Inc. ( NASDAQ:TARS ) shareholders, with the analysts...
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -27.69% | $109.64M | 0.85% |
TAIL | -27.28% | $140.49M | 0.59% |
BTAL | -19.81% | $361.41M | 1.43% |
ULST | -12.51% | $637.77M | 0.2% |
IBTG | -10.43% | $1.88B | 0.07% |
TPMN | -10.28% | $31.54M | 0.65% |
IBTH | -10.06% | $1.53B | 0.07% |
BUXX | -9.94% | $284.43M | 0.25% |
AGZ | -8.58% | $607.46M | 0.2% |
IVOL | -8.54% | $353.94M | 1.02% |
SPTS | -8.49% | $5.76B | 0.03% |
VGSH | -8.33% | $22.38B | 0.03% |
FXY | -8.22% | $838.61M | 0.4% |
UDN | -8.20% | $137.74M | 0.78% |
XHLF | -8.17% | $1.46B | 0.03% |
IBTI | -8.10% | $995.39M | 0.07% |
IEI | -8.06% | $16.09B | 0.15% |
IBTM | -8.04% | $313.33M | 0.07% |
IBTK | -7.91% | $431.59M | 0.07% |
XONE | -7.88% | $603.24M | 0.03% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ADMA | 42.58% | $4.58B | +111.92% | 0.00% |
RYTM | 37.64% | $3.83B | +53.64% | 0.00% |
CRNX | 35.65% | $2.92B | -39.88% | 0.00% |
DNLI | 34.79% | $2.06B | -30.04% | 0.00% |
IOVA | 34.46% | $587.72M | -83.13% | 0.00% |
DNTH | 34.09% | $603.00M | -28.57% | 0.00% |
CELC | 33.44% | $398.07M | -40.43% | 0.00% |
ACLX | 33.30% | $3.22B | +10.72% | 0.00% |
ESTA | 32.81% | $1.06B | -36.82% | 0.00% |
XENE | 32.66% | $2.27B | -26.70% | 0.00% |
TEAM | 32.60% | $58.15B | +21.22% | 0.00% |
SYRE | 32.60% | $877.54M | -61.53% | 0.00% |
IDYA | 32.46% | $1.52B | -58.32% | 0.00% |
RVMD | 32.35% | $7.35B | +1.15% | 0.00% |
CGEM | 32.30% | $427.27M | -69.59% | 0.00% |
IMNM | 32.13% | $696.10M | -44.44% | 0.00% |
DOCN | 31.85% | $2.79B | -17.79% | 0.00% |
RCKT | 31.58% | $724.54M | -71.26% | 0.00% |
OCUL | 31.52% | $1.14B | +14.35% | 0.00% |
EYPT | 31.50% | $393.60M | -54.31% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EVRI | -15.83% | $1.22B | +87.10% | 0.00% |
CNC | -14.53% | $29.89B | -22.14% | 0.00% |
CBOE | -12.12% | $22.95B | +20.67% | 1.12% |
CL | -10.94% | $72.64B | -5.18% | 2.25% |
STG | -10.91% | $27.05M | -37.35% | 0.00% |
FMTO | -10.73% | $45.74M | -99.96% | 0.00% |
AGL | -9.92% | $1.06B | -54.30% | 0.00% |
IEP | -8.94% | $5.28B | -47.19% | 30.85% |
NOC | -8.91% | $67.51B | -0.35% | 1.76% |
PEP | -8.56% | $180.30B | -28.19% | 4.14% |
DLTR | -8.26% | $18.19B | -28.62% | 0.00% |
BF.B | -8.07% | $16.82B | -26.93% | 2.49% |
FIZZ | -7.98% | $4.16B | +0.40% | 0.00% |
VHC | -7.81% | $34.69M | +74.89% | 0.00% |
NUS | -7.68% | $369.12M | -46.10% | 3.20% |
FDP | -7.54% | $1.57B | +33.46% | 4.14% |
LITB | -7.45% | $21.28M | -72.45% | 0.00% |
CPB | -7.35% | $10.42B | -25.16% | 4.36% |
SWBI | -7.11% | $428.59M | -39.84% | 5.35% |
ORLY | -7.04% | $78.08B | +36.20% | 0.00% |